Researchers at Cardiff University, in collaboration with the University of Dundee, have identified a drug molecule within a medicine used to treat tapeworm infections which could lead to new treatments...

Researchers at Binghamton University have developed a new drug that may limit the progression of Parkinson’s disease while providing better symptom relief to potentially hundreds of thousands of...

People with the movement disorder Parkinson’s disease have a much higher risk of the skin cancer melanoma, and vice versa, a Mayo Clinic study finds. While further research is needed into the connection,...

Most cases of Parkinson’s have no known cause, and researchers continue to debate and study possible factors that may contribute to the disease. Research reported in the journal npj Parkinson’s...

The viruses hepatitis B and C may both be associated with an increased risk of Parkinson’s disease, according to a study published in the March 29, 2017, online issue of Neurology®, the medical...

The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa and experiencing...

The Parkinson’s Disease Foundation® (PDF®) is calling upon communities around the US to join the team working to #EndParkinsons during April’s Parkinson’s Awareness Month. PDF urges...

The hepatitis C virus may be associated with an increased risk of developing Parkinson’s disease, according to a study published in the December 23, 2015, online issue of Neurology®, the medical...

Multiple System Atrophy (MSA), a neurodegenerative disorder with similarities to Parkinson’s disease, is caused by a newly discovered type of prion, akin to the misfolded proteins involved in incurable...

The U.S. Food and Drug Administration today approved the Brio Neurostimulation System, an implantable deep brain stimulation device to help reduce the symptoms of Parkinson’s disease and essential tremor,...